Life Science Intellectual Property Review included insights from Life Science Litigation Practice Chair and Patent Litigation Practice Co-chair Sige Gutman in an article discussing recent government efficiency initiatives impacting the US Patent and Trademark Office. The article addresses the potential implications for life sciences companies and considerations for how to navigate the current uncertainty.

Sige says, “People will continue to innovate, research, and develop in the US, and they will continue to rely on patents. As long as we know what the rules of the game are, we can always develop strategies to address any changes."

Source

Life Sciences Intellectual Property Review